Abiopharma

🔍 DANHAKL JOHN G (Executive)

Company: Life Time Group Holdings, Inc. (LTH)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Sold 853,884 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: J | equity_swap_involved: false | shares_owned_after: 2,175,566.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | shares_owned_after: 222,923.00 | Footnotes: F4

Footnotes:

• F1: Represents 853,884 shares of the Issuer's Common Stock, par value $0.01 per share (the "Common Stock") distributed by Green LTF Holdings II LP ("Green LTF") to certain of its limited partners for no consideration in a pro rata in-kind distribution.
• F2: Represents shares of Common Stock owned by Green LTF, LGP Associates VI-A LLC ("Associates VI-A"), and LGP Associates VI-B LLC ("Associates VI-B"). Of the shares of Common Stock reported, 2,120,333 shares are owned by Green LTF, 5,037 shares are owned by Associates VI-A, and 50,206 shares are owned by Associates VI-B.
• F3: Mr. Danhakl directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the securities owned by Green LTF, Associates VI-A, and Associates VI-B. Mr. Danhakl disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
• F4: Includes shares that were previously held indirectly pursuant to the distribution by the Green LTF, described in footnote 1 herein, receipt of which was exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9 and Rule 16a-13 thereunder.